Showing results (541-550 of 1,919) with videos related to
Sort By:
Pageof 192
Cancer Biomarkers : Section a of Disease Markers|November 2, 2016
Screening for the optimal gene and functional gene sets related to breast cancer using differential co-expression and differential expression analysisLei Wang, Hong Ma, Lixia Zhu, et al.Cancer Biomarkers : Section a of Disease Markers|November 2, 2016
Saturated fatty acids as possible important metabolites for epithelial ovarian cancer based on the free and esterified fatty acid profiles determined by GC-MS analysisRui Yin, Tongshu Yang, Hui Su, et al.Cancer Biomarkers : Section a of Disease Markers|November 2, 2016
Knockdown of S100A4 blocks growth and metastasis of anaplastic thyroid cancer cells in vitro and in vivoKejun Zhang, Meiqin Yu, Fengyun Hao, et al.Cancer Biomarkers : Section a of Disease Markers|November 2, 2016
Evaluation of circulating cellular DCLK1 protein, as the most promising colorectal cancer stem cell marker, using immunoassay based methodsAlireza Mirzaei, Zahra Madjd, Azade Amini Kadijani, et al.Cancer Biomarkers : Section a of Disease Markers|October 1, 2016
Glypican-3 and KRT19 are markers associating with metastasis and poor prognosis of pancreatic ductal adenocarcinomaHongliang Yao, Zhulin Yang, Ziru Liu, et al.Cancer Biomarkers : Section a of Disease Markers|January 21, 2017
A polymorphism in mir-34b/c as a potential biomarker for early onset of hereditary retinoblastomaIvna N S R Carvalho, Adriana H O Reis, Anna C E Dos Santos, et al.Cancer Biomarkers : Section a of Disease Markers|January 21, 2017
Urinary NID2 and TWIST1 methylation to augment conventional urine cytology for the detection of bladder cancerJoseph J Fantony, Thomas A Longo, Ajay Gopalakrishna, et al.Cancer Biomarkers : Section a of Disease Markers|January 21, 2017
The alterations of serum FGF-21 levels, metabolic and body composition in early breast cancer patients receiving adjuvant endocrine therapyMurat Akyol, Ahmet Alacacioglu, Leyla Demir, et al.Cancer Biomarkers : Section a of Disease Markers|April 8, 2017
Clinical significance of serum dynamics of HSP90a level in esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapyHongjiang Yan, Baosheng Li, Tingyong Fan, et al.Cancer Biomarkers : Section a of Disease Markers|July 16, 2019
Diagnostic and prognostic value of serum miRNA-1290 in human esophageal squamous cell carcinomaHaijun Sun, Lei Wang, Qingqing Zhao, et al.Pageof 192